Search

everythinglearnresearchcommunity

for

Search:↓

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Energy healing treatment improved L-cysteine's stability, solubility, bioavailability, and shelf-life.

Minoxidil effectively treats severe hypertension, but watch for side effects.

High concentration Minoxidil and Carboxygas effectively treated resistant hair loss with no side effects.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Dutasteride and finasteride affect different cell types differently.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Auxin and ethylene hormones both work together and against each other to control plant growth.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Ethylene and auxin hormones interact in complex ways that are essential for plant growth and development.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Minoxidil increases cell layer permeability by reducing tight junction proteins and raising ROS levels.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.